RxSight, Inc. Common Stock (RXST) is a publicly traded Healthcare sector company. As of July 7, 2026, RXST trades at $5.49 with a market cap of $232.23M and a P/E ratio of -4.93. RXST moved +0.18% today. Year to date, RXST is -48.10%; over the trailing twelve months it is -57.09%. Its 52-week range spans $4.48 to $47.89. Analyst consensus is neutral with an average price target of $9.67. Rallies surfaces RXST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for RXST shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.49 |
| Market Cap | $232.23M |
| P/E Ratio | -4.93 |
| EPS | $-1.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.89 |
| 52-Week Low | $4.48 |
| Volume | 865.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $127.48M |
| Net Income | $-46.64M |
| Gross Margin | 77.02% |
6 analysts cover RXST: 0 strong buy, 1 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $9.67.